We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
(+14%)
Cap. Flow
-$1.58B
Cap. Flow
% of AUM
-0.53%
Top 10 Holdings %
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1B |
| 2 |
Apple
AAPL
|
+$797M |
| 3 |
Merck
MRK
|
+$316M |
| 4 |
Amazon
AMZN
|
+$308M |
| 5 |
Medtronic
MDT
|
+$298M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$587M |
| 2 |
NXP Semiconductors
NXPI
|
+$554M |
| 3 |
Meta Platforms (Facebook)
META
|
+$449M |
| 4 |
Intuit
INTU
|
+$433M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.73% |
| 2 | Healthcare | 13.29% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Financials | 12.2% |
| 5 | Communication Services | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
2001
DELISTED
Immunogen Inc
IMGN
| $5.55M | ﹤0.01% |
860,912
+26,609
| +3% | +$155K |
|
2002
Pitney Bowes
PBI
$2.39B
| $5.55M | ﹤0.01% |
900,525
+17,936
| +2% | +$108K |
|
2003
Alamo Group
ALG
$2.05B
| $5.52M | ﹤0.01% |
40,035
-4,949
| -11% | -$641K |
|
2004
Zentalis Pharmaceuticals
ZNTL
$302M
| $5.5M | ﹤0.01% |
105,992
+65,359
| +161% | +$2.95M |
|
2005
The Greenbrier Companies
GBX
$1.46B
| $5.5M | ﹤0.01% |
151,170
+3,361
| +2% | +$111K |
|
2006
Reynolds Consumer Products
REYN
$5.59B
| $5.5M | ﹤0.01% |
182,924
-310,781
| -63% | -$9.4M |
|
|
AERI
2007
DELISTED
Aerie Pharmaceuticals
AERI
| $5.5M | ﹤0.01% |
406,733
-191,751
| -32% | -$2.32M |
|
2008
iQIYI
IQ
$1.28B
| $5.47M | ﹤0.01% |
313,168
+35,268
| +13% | +$796K |
|
2009
Acadia Realty Trust
AKR
$2.84B
| $5.47M | ﹤0.01% |
385,480
-18,696
| -5% | -$235K |
|
2010
iShares MSCI EAFE ETF
EFA
$80.2B
| $5.44M | ﹤0.01% |
74,603
-2,565,935
| -97% | -$175M |
|
2011
QCR Holdings
QCRH
$1.7B
| $5.43M | ﹤0.01% |
137,254
-15,025
| -10% | -$525K |
|
2012
Castle Biosciences
CSTL
$979M
| $5.42M | ﹤0.01% |
80,793
-3,509
| -4% | -$190K |
|
2013
Universal Corp
UVV
$1.27B
| $5.42M | ﹤0.01% |
111,508
-1,728
| -2% | -$77.8K |
|
2014
Marcus & Millichap
MMI
$1.19B
| $5.4M | ﹤0.01% |
145,089
+26,639
| +22% | +$902K |
|
2015
Codexis
CDXS
$158M
| $5.4M | ﹤0.01% |
247,345
+18,394
| +8% | +$303K |
|
2016
QuinStreet
QNST
$1.21B
| $5.4M | ﹤0.01% |
251,769
+1,001
| +0.4% | +$18.3K |
|
2017
Safety Insurance
SAFT
$1.52B
| $5.38M | ﹤0.01% |
69,037
-541
| -0.8% | -$39.7K |
|
2018
Collegium Pharmaceutical
COLL
$956M
| $5.37M | ﹤0.01% |
268,266
-12,171
| -4% | -$238K |
|
2019
PTC Therapeutics
PTCT
$6.12B
| $5.36M | ﹤0.01% |
258,115
-2,914
| -1% | -$172K |
|
2020
nLIGHT
LASR
$3.17B
| $5.36M | ﹤0.01% |
164,012
+10,465
| +7% | +$296K |
|
2021
Relay Therapeutics
RLAY
$4.33B
| $5.35M | ﹤0.01% |
128,691
+2,652
| +2% | +$120K |
|
2022
Oxford Industries
OXM
$552M
| $5.34M | ﹤0.01% |
81,574
-555
| -0.7% | -$28.7K |
|
|
JOYY
2023
JOYY Inc
JOYY
$3.75B
| $5.32M | ﹤0.01% |
66,520
-3,784
| -5% | -$325K |
|
2024
Arcus Biosciences
RCUS
$3.64B
| $5.32M | ﹤0.01% |
204,789
-11,563
| -5% | -$280K |
|
|
AAN
2025
DELISTED
The Aaron's Company Inc
AAN
| $5.31M | ﹤0.01% |
+280,266
| New | +$5.16M |
|
Similar funds
VFT
Nuveen's Q4 2020 Portfolio in Review
As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
- Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
- Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
- Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
- Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
- Nuveen opened 145 new positions and closed 125 in Q4 2020.
- Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.
Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.